How do I read a treatment claim?

Were the participants like me?

The main study behind the old children’s treatment gave sermorelin to 110 children with too little growth hormone. That is a chemical message the body makes to help children grow. Of those children, 86 met the study’s rules for measuring how well treatment worked.

The source summary used for this guide does not explain why the other 24 children were left out of that calculation. Ask about those missing results before relying on the findings.

There was no separate group of children to compare the treated children with.

That tells a different story from a trial designed to test an adult’s sleep, energy or body fat.

Was it the same substance?

The 16-week adult study used a modified version of the hormone rather than sermorelin itself.

That matters when someone uses it to support a sermorelin claim. Ask to see the substance named in the paper.

What changed for the participants?

Blood hormone measurements rose in the small adult studies, but the studies that assessed body fat found no change.

Write the promised outcome next to the measured outcome. Do the words describe the same thing?

Does a government record answer the right question?

The Food and Drug Administration (FDA) explained Geref’s withdrawal in March 2013. It said the old sermorelin medicine had left the market for reasons other than safety problems or failure to work.

That decision explained why sales ended. It did not show benefits for adults or approve a medicine made by a pharmacy today.

Keep the date and the exact question beside any approval claim.